Literature DB >> 23070368

Ulcerative colitis: UCCIS--a reproducible tool to assess mucosal healing.

Helmut Neumann, Markus F Neurath.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23070368     DOI： 10.1038/nrgastro.2012.198

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  9 in total

1.  Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease.

Authors:  Marco Daperno; Fabiana Castiglione; Lissy de Ridder; Iris Dotan; Martti Färkkilä; Jon Florholmen; Gerald Fraser; Walter Fries; Xavier Hebuterne; Peter Laszlo Lakatos; Julián Panés; Jordi Rimola; Edouard Louis
Journal:  J Crohns Colitis       Date:  2011-08-11       Impact factor: 9.071

2.  Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease.

Authors:  Laurent Peyrin-Biroulet; Marc Ferrante; Fernando Magro; Simon Campbell; Denis Franchimont; Herma Fidder; Hans Strid; Sandro Ardizzone; Gigi Veereman-Wauters; Jean-Baptiste Chevaux; Mathieu Allez; Silvio Danese; Andreas Sturm
Journal:  J Crohns Colitis       Date:  2011-08-03       Impact factor: 9.071

Review 3.  New endoscopic approaches in IBD.

Authors:  Helmut Neumann; Markus F Neurath; Jonas Mudter
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

4.  Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity.

Authors:  Kelvin T Thia; Edward V Loftus; Darrell S Pardi; Sunanda V Kane; William A Faubion; William J Tremaine; Kenneth W Schroeder; Scott W Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2010-09-27       Impact factor: 5.325

Review 5.  A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

Authors:  Geert D'Haens; William J Sandborn; Brian G Feagan; Karel Geboes; Stephen B Hanauer; E Jan Irvine; Marc Lémann; Philippe Marteau; Paul Rutgeerts; Jurgen Schölmerich; Lloyd R Sutherland
Journal:  Gastroenterology       Date:  2006-12-20       Impact factor: 22.682

Review 6.  Mucosal healing in inflammatory bowel diseases: a systematic review.

Authors:  Markus F Neurath; Simon P L Travis
Journal:  Gut       Date:  2012-07-27       Impact factor: 23.059

7.  Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures.

Authors:  Sunil Samuel; David H Bruining; Edward V Loftus; Kelvin T Thia; Kenneth W Schroeder; William J Tremaine; William A Faubion; Sunanda V Kane; Darrell S Pardi; Piet C de Groen; William S Harmsen; Alan R Zinsmeister; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-16       Impact factor: 11.382

Review 8.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  Craig Mowat; Andrew Cole; Al Windsor; Tariq Ahmad; Ian Arnott; Richard Driscoll; Sally Mitton; Tim Orchard; Matt Rutter; Lisa Younge; Charlie Lees; Gwo-Tzer Ho; Jack Satsangi; Stuart Bloom
Journal:  Gut       Date:  2011-05       Impact factor: 23.059

9.  Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).

Authors:  Simon P L Travis; Dan Schnell; Piotr Krzeski; Maria T Abreu; Douglas G Altman; Jean-Frédéric Colombel; Brian G Feagan; Stephen B Hanauer; Marc Lémann; Gary R Lichtenstein; Phillippe R Marteau; Walter Reinisch; Bruce E Sands; Bruce R Yacyshyn; Christian A Bernhardt; Jean-Yves Mary; William J Sandborn
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059
  9 in total
  3 in total

1.  Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse.

Authors:  Natsuki Ishida; Shunya Onoue; Takahiro Miyazu; Satoshi Tamura; Shinya Tani; Mihoko Yamade; Moriya Iwaizumi; Yasushi Hamaya; Satoshi Osawa; Takahisa Furuta; Ken Sugimoto
Journal:  Int J Colorectal Dis       Date:  2021-08-18       Impact factor: 2.571

Review 2.  How to assess endoscopic disease activity in ulcerative colitis in 2022.

Authors:  Mirko Di Ruscio; Marco Cedola; Manuela Mangone; Stefano Brighi
Journal:  Ann Gastroenterol       Date:  2022-07-11

3.  C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis.

Authors:  Natsuki Ishida; Tomohiro Higuchi; Takahiro Miyazu; Satoshi Tamura; Shinya Tani; Mihoko Yamade; Moriya Iwaizumi; Yasushi Hamaya; Satoshi Osawa; Takahisa Furuta; Ken Sugimoto
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.